{
    "clinical_study": {
        "@rank": "40097", 
        "arm_group": [
            {
                "arm_group_label": "FX2-2-2", 
                "arm_group_type": "Experimental", 
                "description": "Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 \u03bcg/kg/hr of fentanyl) were maintained at the fixed-rate of 2 ml/hr until the postoperative 24 hr"
            }, 
            {
                "arm_group_label": "D6-4-2", 
                "arm_group_type": "Active Comparator", 
                "description": "Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 \u03bcg/kg/hr of fentanyl) were maintained at the decremental rates of 6.0 ml/hr (D6-4-2) during 1 hr, 4.0 ml/hr during 1~3 hr and 2.0 ml/hr during 3~24 hr,"
            }, 
            {
                "arm_group_label": "D8-4-2", 
                "arm_group_type": "Active Comparator", 
                "description": "Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 \u03bcg/kg/hr of fentanyl) were maintained at at the decremental rates of 8.0 ml/hr (D8-4-2) during 1 hr, 4.0 ml/hr during 1~3 hr and 2.0 ml/hr during 3~24 hr,"
            }
        ], 
        "brief_summary": {
            "textblock": "We investigated the efficacy and the safety of the pharmacokinetic model-based\n      patient-controlled analgesia (PCA) regimens of fentanyl for postoperative analgesia after\n      total intravenous anesthesia (TIVA)."
        }, 
        "brief_title": "Fentanyl Background Infusion for Acute Postoperative Pain", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Analgesia Disorder", 
        "detailed_description": {
            "textblock": "Infusions of fentanyl (2 ml/hr of diluent was equivalent with 0.5 \u03bcg/kg/hr of fentanyl) were\n      maintained at the fixed-rate of 2 ml/hr until the postoperative 24 hr, or at the decremental\n      rates of 6.0 ml/hr or 8.0 ml/hr during 1 hr, 4.0 ml/hr during 1~3 hr and 2.0 ml/hr during\n      3~24 hr, postoperatively."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients who had undergone patient-controlled analgesia (PCA) after hysterectomy\n\n        Exclusion Criteria:\n\n          -  neurologic disorders\n\n          -  psychiatric disorders\n\n          -  renal or hepatic disorders"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "99", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01785823", 
            "org_study_id": "AJIRB-DEV-DE1-11-288"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "D6-4-2", 
                    "D8-4-2"
                ], 
                "description": "Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 \u03bcg/kg/hr of fentanyl) were maintained at the fixed-rate of 2 ml/hr until the postoperative 24 hr (FX2-2-2), or at the decremental rates of 6.0 ml/hr (D6-4-2) and 8.0 ml/hr (D8-4-2) during 1 hr, 4.0 ml/hr during 1~3 hr and 2.0 ml/hr during 3~24 hr, postoperatively. The visual analogue scores (VAS), the incidence of inadequate analgesia, the frequency of intervention of PCA, and side effects were evaluated.", 
                "intervention_name": "FX2-2-2", 
                "intervention_type": "Other", 
                "other_name": "decremental PCA"
            }, 
            {
                "arm_group_label": [
                    "FX2-2-2", 
                    "D8-4-2"
                ], 
                "description": "Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 \u03bcg/kg/hr of fentanyl) were maintained at the fixed-rate of 2 ml/hr until the postoperative 24 hr (FX2-2-2), or at the decremental rates of 6.0 ml/hr (D6-4-2) and 8.0 ml/hr (D8-4-2) during 1 hr, 4.0 ml/hr during 1~3 hr and 2.0 ml/hr during 3~24 hr, postoperatively. The visual analogue scores (VAS), the incidence of inadequate analgesia, the frequency of intervention of PCA, and side effects were evaluated.", 
                "intervention_name": "D6-4-2", 
                "intervention_type": "Other", 
                "other_name": "decremantl PCA 6-4-2"
            }, 
            {
                "arm_group_label": [
                    "FX2-2-2", 
                    "D6-4-2"
                ], 
                "description": "Their background infusions of fentanyl diluent (2 ml/hr of diluent was equivalent with 0.5 \u03bcg/kg/hr of fentanyl) were maintained at the fixed-rate of 2 ml/hr until the postoperative 24 hr (FX2-2-2), or at the decremental rates of 6.0 ml/hr (D6-4-2) and 8.0 ml/hr (D8-4-2) during 1 hr, 4.0 ml/hr during 1~3 hr and 2.0 ml/hr during 3~24 hr, postoperatively. The visual analogue scores (VAS), the incidence of inadequate analgesia, the frequency of intervention of PCA, and side effects were evaluated.", 
                "intervention_name": "D8-4-2", 
                "intervention_type": "Other", 
                "other_name": "decremental PCA 8-4-2"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Fentanyl"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "analgesia", 
            "fentanyl", 
            "total intravenous anesthesia"
        ], 
        "lastchanged_date": "February 6, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Suwon", 
                    "country": "Korea, Republic of", 
                    "state": "Gyeongki-do", 
                    "zip": "443-721"
                }, 
                "name": "Ajou University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Efficacy of the Time-scheduled Decremental Continuous Infusion of Fentanyl for Postoperative Patient-controlled Analgesia After Total Intravenous Anesthesia", 
        "overall_official": {
            "affiliation": "Ajou University", 
            "last_name": "Jong Yeop Kim, M.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The assessments of analgesia and patient condition were performed at the time points of immediate post-operative periods (1, 15, 30, 45, and 60 min) and post-operative 2, 3, 4, 6, 12 and 24 hr.", 
            "measure": "visual analogue scores (VAS)", 
            "safety_issue": "Yes", 
            "time_frame": "until post-operative 24 hrs"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01785823"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ajou University School of Medicine", 
            "investigator_full_name": "Jong Yeop Kim", 
            "investigator_title": "Associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Ajou University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ajou University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}